| Ten Years with New Delhi Metallo-beta-lactamase-1 (NDM-1): From Structural Insights to Inhibitor Design |
28 |
| New Perspectives in Biofilm Eradication |
22 |
| Developments in Glycopeptide Antibiotics |
22 |
| Plazomicin Retains Antibiotic Activity against Most Aminoglycoside Modifying Enzymes |
21 |
| Antibiotic Resistance ABC-F Proteins: Bringing Target Protection into the Limelight |
19 |
| Pyrazolo[5-a]pyridine Inhibitor of the Respiratory Cytochrome bcc Complex for the Treatment of Drug-Resistant Tuberculosis |
18 |
| Antimicrobial and Antibiofilm Activity of Human Milk Oligosaccharides against Streptococcus agalactiae, Staphylococcus aureus, and Acinetobacter baumannii |
18 |
| Probing the Interaction of Aspergillomarasmine A with Metallo-beta-lactamases NDM- VIM- and IMP-7 |
17 |
| A Comparison of Optical, Electrochemical, Magnetic, and Colorimetric Point-of-Care Biosensors for Infectious Disease Diagnosis |
17 |
| Engineered Probiotic for the Inhibition of Salmonella via Tetrathionate-Induced Production of Microcin H47 |
16 |
| Direct Inhibition of MmpL3 by Novel Antitubercular Compounds |
14 |
| Aurein-Derived Antimicrobial Peptides Formulated with Pegylated Phospholipid Micelles to Target Methicillin-Resistant Staphylococcus aureus Skin Infections |
14 |
| Targeting the Proteostasis Network for Discovery |
14 |
| Interrogation of Human Milk Oligosaccharide Fucosylation Patterns for Antimicrobial and Antibiofilm Trends in Group B Streptococcus |
14 |
| Synergy between Synthetic Antimicrobial Polymer and Antibiotics: A Promising Platform To Combat Multidrug-Resistant Bacteria |
14 |
| Antibacterial Drug Discovery: Some Assembly Required |
13 |
| Two-Component Ferritin Nanoparticles for Multimerization of Diverse Trimeric Antigens |
13 |
| REP 2139: Antiviral Mechanisms and Applications in Achieving Functional Control of HBV and HDV Infection |
13 |
| Getting Drugs into Gram-Negative Bacteria: Rational Rules for Permeation through General Porins |
13 |
| (p)ppGpp and the Stringent Response: An Emerging Threat to Antibiotic Therapy |
13 |
| [C-11]Para-Aminobenzoic Acid: A Positron Emission Tomography Tracer Targeting Bacteria-Specific Metabolism |
13 |
| Genetically Validated Drug Targets in Leishmania: Current Knowledge and Future Prospects |
13 |
| Design of Next Generation Polymyxins with Lower Toxicity: The Discovery of SPR206 |
13 |
| SAR Studies Leading to the Identification of a Novel Series of Metallo-beta-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model |
13 |
| Discovery and Mechanistic Study of a Novel Human-Stimulator-of-Interferon-Genes Agonist |
12 |
| Discovery and Optimization of nTZDpa as an Antibiotic Effective Against Bacterial Persisters |
12 |
| The Expanding Diversity of Mycobacterium tuberculosis Drug Targets |
12 |
| Challenges in the Development of a Thiol-Based Broad-Spectrum Inhibitor for Metallo-beta-Lactamases |
12 |
| Mechanistic and Structural Basis for the Actions of the Antibacterial Gepotidacin against Staphylococcus aureus Gyrase |
11 |
| Fluoxetine Inhibits Enterovirus Replication by Targeting the Viral 2C Protein in a Stereospecific Manner |
11 |
| Fragment-Based Screening of a Natural Product Library against 62 Potential Malaria Drug Targets Employing Native Mass Spectrometry |
11 |
| Positron Emission Tomography Imaging with 2-[F-18]F-p-Aminobenzoic Acid Detects Staphylococcus aureus Infections and Monitors Drug Response |
10 |
| Siderophore Conjugates of Daptomycin are Potent Inhibitors of Carbapenem Resistant Strains of Acinetobacter baumannii |
10 |
| Immucillins in Infectious Diseases |
10 |
| The Therapeutic Pipeline for Pseudomonas aeruginosa Infections |
10 |
| Pharmacological Validation of N-Myristoyltransferase as a Drug Target in Leishmania donovani |
10 |
| Molecular Properties That Define the Activities of Antibiotics in Escherichia coli and Pseudomonas aeruginosa |
10 |
| ARB- a RNA Interference Therapeutic for Chronic Hepatitis B Infection |
10 |
| Violacein Targets the Cytoplasmic Membrane of Bacteria |
10 |
| Bicarbonate Alters Bacterial Susceptibility to Antibiotics by Targeting the Proton Motive Force |
10 |
| Kill the Real with the Fake: Eliminate Intracellular Staphylococcus aureus Using Nanoparticle Coated with Its Extracellular Vesicle Membrane as Active-Targeting Drug Carrier |
9 |
| Oncolytic Viruses on Drugs: Achieving Higher Therapeutic Efficacy |
9 |
| Fluorescence Imaging of Bacterial Killing by Antimicrobial Peptide Dendrimer G3KL |
9 |
| Cyclipostins and Cyclophostin Analogues as Multitarget Inhibitors That Impair Growth of Mycobacterium abscessus |
9 |
| Increased Degree of Unsaturation in the Lipid of Antifungal Cationic Amphiphiles Facilitates Selective Fungal Cell Disruption |
9 |
| IID572: A New Potentially Best-In-Class beta-Lactamase Inhibitor |
9 |
| Short Cationic Peptide Derived from Archaea with Dual Antibacterial Properties and Anti-Infective Potential |
9 |
| LRRK2 in Infection: Friend or Foe? |
9 |
| Signed, Sealed, Delivered: Conjugate and Prodrug Strategies as Targeted Delivery Vectors for Antibiotics |
9 |
| Phagosomal Copper-Promoted Oxidative Attack on Intracellular Mycobacterium tuberculosis |
9 |
